Prelude Capital Management, LLC Clovis Oncology, Inc. Call Options Transaction History

Prelude Capital Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	SELL	$5.69 - $9.69 $569 - $969	-100 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $300 - $1,643	-100 Reduced 50.0%	100 $1,000
Q2 2019 Aug 14, 2019	SELL	$12.81 - $25.67 $1,281 - $2,567	-100 Reduced 33.33%	200 $3,000
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $5,298 - $9,084	300 New	300 $7,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.